Based on the NAFLD guidelines by the North American Society Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), overweight or obese child above 8 years old with chronically elevated alanine aminotransferase (ALT) and identified risk factors should be screened for NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.